Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Brigham and Women's Hospital
Boston, Massachusetts
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 148
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Gerald Pier | Conflict of Interest | OneBiopharma | 2019 | |
| Sebastian Schneeweiss | Conflict of Interest | Aetion, Inc. | 2017 | |
| Khalid Shah | Conflict of Interest | AMASA Technologies | 2019 | |
| David White | Conflict of Interest | Apnicure, Inc. | 2016 | |
| Jie Shen | Conflict of Interest | iNeuro Therapeutics, Inc. | 2019 | |
| Vitaly Napadow | Conflict of Interest | NeuroPhase Inc. | 2018 | |
| Richard Blumberg | Conflict of Interest | Syntalogic | 2015 | |
| Jonathan Thon | Conflict of Interest | Platelet BioGenesis | 2014 | |
| Robert Sackstein | Conflict of Interest | Warrior Therapeutics LLC | 2015 | |
| Nobuhiko Hata | Conflict of Interest | Mebio, Inc. | 2015 | |
| Gerald Pier | Conflict of Interest | Alopexx Pharmaceuticals/Alopexx Vaccines | 2014 | |
| Christian Lorson | Conflict of Interest | Shift Pharmaceuticals | 2017 | |
| Nobuhiko Hata | Conflict of Interest | Mebio, Inc. | 2015 | |
| Omid Farokhzad | Conflict of Interest | Selecta Biosciences | 2013 | |
| Khalid Shah | Conflict of Interest | AMASA Technologies | 2017 | |
| Khalid Shah | Conflict of Interest | AMASA Technologies | 2017 | |
| Khalid Shah | Conflict of Interest | AMASA Technologies | 2017 | |
| Catherine Wu | Conflict of Interest | Neon Therapeutics | 2018 | |
| Bruce Levy | Conflict of Interest | Resolvyx Pharmaceuticals | 2016 | |
| Charles Serhan | Conflict of Interest | Resolvyx Pharmaceuticals | 2016 | |
| Shiladitya Sengupta | Conflict of Interest | Mitra Biotech Pvt. Ltd. (formerly know as Mitra Life Sciences) | 2017 | |
| Nobuhiko Hata | Conflict of Interest | Harmonus | 2016 | |
| Richard Blumberg | Conflict of Interest | Syntalogic | 2016 | |
| Hadi Shafiee | Conflict of Interest | Firtility, Inc. | 2019 | |
| Vijay Kuchroo | Conflict of Interest | Celsius Therapeutics | 2018 | |
| Paul Yu | Conflict of Interest | Keros Therapeutics | 2017 | |
| Paul Yu | Conflict of Interest | Keros Therapeutics | 2017 | |
| Joseph Bonventre | Conflict of Interest | Goldfinch Biopharma, Inc. | 2017 | |
| Gary Curhan | Conflict of Interest | Allena Pharmaceuticals, Inc. | 2017 | |
| David Wellman | Conflict of Interest | Apnimed Corp. | 2018 | |
| David Wellman | Conflict of Interest | Apnimed Corp. | 2018 | |
| David Wellman | Conflict of Interest | Apnimed Corp. | 2018 | |
| Paul Yu | Conflict of Interest | Keros Therapeutics | 2018 | |
| Jie Shen | Conflict of Interest | iNeuro Therapeutics | 2018 | |
| Jie Shen | Conflict of Interest | iNeuro Therapeutics | 2018 | |
| Jie Shen | Conflict of Interest | iNeuro Therapeutics | 2018 | |
| Francisco Quintana | Conflict of Interest | AnTolRx, Inc. | 2017 | |
| Daniel Needleman | Conflict of Interest | LuminOva | 2018 | |
| Francisco Quintana | Conflict of Interest | AnTolRx, Inc. | 2017 | |
| Anna Greka | Conflict of Interest | Goldfinch Biopharma, Inc. | 2017 | |
| Anna Greka | Conflict of Interest | Goldfinch Biopharma, Inc. | 2017 | |
| Jerrold Turner | Conflict of Interest | Thelium Therapeutics | 2019 | |
| Georg Gerber | Conflict of Interest | Kaleido Biosciences, Inc. | 2018 | |
| Robert Green | Conflict of Interest | Genome Medical, Inc. | 2018 | |
| Jayender Jagadeesan | Conflict of Interest | Navigation Sciences, Inc. | 2018 | |
| Raphael Bueno | Conflict of Interest | Navigation Sciences, Inc. | 2018 | |
| Richard Blumberg | Conflict of Interest | Syntimmune, Inc. | 2017 | |
| Paul Yu | Conflict of Interest | Keros Therapeutics | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.